Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel

Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel

Zuzana Motovska, Petr WidimskyThird Medical Faculty of Charles University and University Hospital Kralovske Vinohrady, Prague, Czech RepublicAbstract: Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a rapid increase in the use of coronary intervention procedures. Clopidogr...

Full description

Bibliographic Details
Main Authors:	Zuzana Motovska, Petr Widimsky
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-05-01
Series:	Vascular Health and Risk Management
Online Access:	http://www.dovepress.com/improving-outcomes-in-patients-undergoing-percutaneous-coronary-interv-a3157

Similar Items

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
by: J Greenhalgh, et al.
Published: (2010-05-01)

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
by: J Greenhalgh, et al.
Published: (2010-05-01)

PRASUGREL FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTION: STATUS UPDATE ON THE PROBLEM
by: O. O. Shakhmatova, et al.
Published: (2018-05-01)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
by: Shokoufeh Hajsadeghi, et al.
Published: (2016-08-01)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
by: Shokoufeh Hajsadeghi, et al.
Published: (2016-01-01)

Prasugrel Inappropriate Use in Patients Post-percutaneous coronary intervention (PCI). A Single Center Study
by: Ahmed Amro, et al.
Published: (2019-07-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention.
by: Yuri Kim, et al.
Published: (2023-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
by: Yuri Kim, et al.
Published: (2023-01-01)

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
by: Janette Greenhalgh, et al.
Published: (2015-04-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine
by: César E. Soria Jiménez, et al.
Published: (2023-05-01)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
by: Maximilian Tscharre, et al.
Published: (2022-03-01)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2018-05-01)

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials
by: Zuzana Motovska, et al.
Published: (2023-01-01)

Prasugrel
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention
by: Magdalena Sionova, et al.
Published: (2017-09-01)

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. Yu. Gilyarov, et al.
Published: (2018-05-01)

Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.
by: Hideki Kitahara, et al.
Published: (2022-01-01)

Contrast volume and in-hospital outcomes of dialysis patients undergoing percutaneous coronary intervention
by: Toshiki Kuno, et al.
Published: (2022-10-01)

Thirty day outcomes of Indian patients in a multicenteric hospital registry of patients with acute coronary syndrome (ACS) undergoing PCI treated with prasugrel
by: A. Omar, et al.
Published: (2014-11-01)

The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery
by: Erich Moresco, et al.
Published: (2023-03-01)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
by: Vasiliki Tsoulou, et al.
Published: (2023-05-01)

Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
by: Mattia Galli, et al.
Published: (2022-08-01)

Study to assess improvement in therapeutic outcomes by platelet inhibition with prasugrel
by: Amit Madaan
Published: (2015-12-01)

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
Published: (2023-01-01)

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.
by: Hideki Kitahara, et al.
Published: (2023-01-01)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: Zuhdi, A.S., et al.
Published: (2013)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: AS Zuhdi, et al.
Published: (2013-11-01)

Effectiveness of “percutaneous coronary intervention care program” on selected variables among patients undergoing percutaneous coronary intervention
by: Poonam Sharma, et al.
Published: (2018-01-01)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
by: Tianyu Li, et al.
Published: (2021-12-01)

Risk stratification algorithm for clinical outcomes in anemic patients undergoing percutaneous coronary intervention
by: Bingbing Ke, et al.
Published: (2023-12-01)

Gender-specific cardiovascular outcomes in patients undergoing percutaneous coronary intervention in Chinese populations
by: Juan Long, et al.
Published: (2020-06-01)

Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention
by: Zhang JJ, et al.
Published: (2016-05-01)

Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
by: Mohitosh Biswas, et al.
Published: (2021-07-01)

Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention
by: Marco Cattaneo
Published: (2023-06-01)

Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
by: Yasushi Ueki, MD, et al.
Published: (2019-12-01)

Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention
by: Yudi Her Oktaviono, et al.
Published: (2021-01-01)

Oxidant and antioxidant status in patients undergoing percutaneous coronary interventions
by: Vonteru Lakshmi Asha Latha
Published: (2017-03-01)

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Matthias Bossard, et al.
Published: (2017-11-01)